These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1349259)

  • 21. Effects of loratadine and terfenadine on the induced nasal allergic reaction.
    Baroody FM; Lim MC; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):309-16. PubMed ID: 8607960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.
    Twentyman OP; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1993 Jun; 91(6):1169-78. PubMed ID: 8099592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arachidonic acid metabolites during nasal challenge.
    Brown MS; Peters SP; Adkinson NF; Proud D; Kagey-Sobotka A; Norman PS; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):179-83. PubMed ID: 3099812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air.
    Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):761-5. PubMed ID: 1706910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mediator release during the early reaction to antigen.
    Naclerio RM
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 2):715-9. PubMed ID: 1401653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season.
    Wang D; Smitz J; De Waele M; Clement P
    Int Arch Allergy Immunol; 1997 Oct; 114(2):185-92. PubMed ID: 9338613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-provoked increase in histamine reactivity. Observations on mechanisms.
    Walden SM; Proud D; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):642-8. PubMed ID: 1892305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azelastine reduces histamine-induced swelling of nasal mucosa.
    Spaeth J; Schultze V; Klimek L; Lengersdorf A; Mosges R
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(3):157-63. PubMed ID: 8797220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
    Arcimowicz M; Samoliński B; Zawisza E
    Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinins as mediators of human allergic reactions.
    Proud D; Naclerio RM; Togias AG; Kagey-Sobotka A; Adkinson NF; Norman PA; Lichtenstein LM
    Adv Exp Med Biol; 1986; 198 Pt B():181-7. PubMed ID: 3812100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of loratadine on allergen-induced histamine release in the nose.
    Andersson M; Nolte H; Baumgarten C; Pipkorn U
    Allergy; 1991 Oct; 46(7):540-6. PubMed ID: 1724592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
    Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ; Lund VJ; Harten-Ash VJ
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
    Pipkorn U; Proud D; Lichtenstein LM; Kagey-Sobotka A; Norman PS; Naclerio RM
    N Engl J Med; 1987 Jun; 316(24):1506-10. PubMed ID: 2438553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
    Pearlman DS; Grossman J; Meltzer EO
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
    Lieberman PL; Settipane RA
    Allergy Asthma Proc; 2003; 24(2):95-105. PubMed ID: 12776442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.